令人心醉 发表于 2025-3-23 12:25:58

http://reply.papertrans.cn/1/91/9069/9069-11.png

Meditate 发表于 2025-3-23 15:04:51

Submitted on: 28 September 2002.
Revised on: 13 November 2002.
Accepted on: 17 December 2002.

___________________European Heart Journal-Cardiovascular Pharmacotherapy

RAGE 发表于 2025-3-23 19:50:47

http://reply.papertrans.cn/1/91/9069/9069-13.png

nonradioactive 发表于 2025-3-24 00:51:04

Submitted on: 01 February 2013.
Revised on: 12 March 2013.
Accepted on: 27 April 2013.

___________________European Heart Journal-Cardiovascular Pharmacotherapy

恫吓 发表于 2025-3-24 05:46:41

Submitted on: 09 March 2003.
Revised on: 04 July 2003.
Accepted on: 25 August 2003.

___________________European Heart Journal-Cardiovascular Pharmacotherapy

无目标 发表于 2025-3-24 07:12:33

Submitted on: 28 October 2016.
Revised on: 02 February 2017.
Accepted on: 13 March 2017.

___________________European Heart Journal-Cardiovascular Pharmacotherapy

Obliterate 发表于 2025-3-24 11:47:19

Submitted on: 18 November 2015.
Revised on: 01 February 2016.
Accepted on: 22 February 2016.

___________________European Heart Journal-Cardiovascular Pharmacotherapy

Spangle 发表于 2025-3-24 16:10:08

http://reply.papertrans.cn/1/91/9069/9069-18.png

性满足 发表于 2025-3-24 21:50:10

http://reply.papertrans.cn/1/91/9069/9069-19.png

内部 发表于 2025-3-25 01:29:18

Submitted on: 22 October 2024.
Revised on: 16 January 2025.
Accepted on: 07 March 2025.

___________________European Heart Journal-Cardiovascular Pharmacotherapy
页: 1 [2] 3 4
查看完整版本: SCIE期刊European Heart Journal-Cardiovascular Pharmacotherapy 2024/2025影响因子:5.387 (EUR HEART J-CARD PHA) (2055-6837). (PH